Client & Alumni News

Saladax Launches New Website to Promote the MyCare Line in Psychiatry and Oncology

Saladax is Advancing Personalized Medicine by Providing Doctors with the Diagnostic Tools to Treat Patients Better 

Saladax Biomedical Inc., a diagnostics company providing kits to test drug blood levels for adherence and personized dose management, unveiled its new MyCare Product website at The website comes just days before the company expects CE Mark on its new MyCare Psychiatry antipsychotic drug level tests. With updated functionality and a new look and feel, Saladax Biomedical’s website now features enhanced search capabilities, progressive user interface, and easily accessible information for psychiatrists and oncologists, laboratorians, patients, researchers, and distributors.  

“Saladax continues to look for ways to advance personalized medicine,” said Saladax CEO, Salvatore Salamone. “We hope our new website will provide a valuable resource for doctors and patients to better understand the benefits of not only personalizing the drug but also taking the right dose. We understand that this information is critical and getting the results back to the doctor within a meaningful timeframe is essential. Saladax is especially excited about our new MyCare Psychiatry line of antipsychotic tests which can provide information to the doctors as to why their patient may be failing treatment. We will not fully achieve the promise of personalized medicine unless we are able to ensure adherence of a personalized drug dose on an individual basis.” 

Visit or